Internal Medicine, Endocrinology, Diabetes, & Metabolism · Clifton, NJ
NPI
1174551824
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
969 Paulison Ave
Clifton, NJ, 07011
Phone (973) 546-3355
Groups this clinician bills Medicare through
Medicare paid, 2024
$127K
1,785 services
Medicare patients, 2024
361
Average age 72
Drug cost, 2024
$4.2M
12,736 prescriptions
Company payments, 2025
$363
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saleh Khaddash was code 99232 (hospital e&m - subsequent), 587 times for 93 patients. In total Saleh Khaddash billed 1,785 services in 18 codes, and Medicare paid $127K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 587 | 93 | $69.43 | $41K |
| 99214 Office E&M - Established | Office | 536 | 237 | $99.90 | $54K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 302 | 166 | $14.39 | $4,346 |
| 95251 Test - Miscellaneous | Office | 77 | 33 | $30.11 | $2,318 |
| 99223 Hospital E&M - Initial | Facility | 56 | 50 | $139.27 | $7,799 |
| 99222 Hospital E&M - Initial | Facility | 56 | 53 | $115.30 | $6,457 |
| 99204 Office E&M - New | Office | 45 | 45 | $126.11 | $5,675 |
| 99233 Hospital E&M - Subsequent | Facility | 30 | 19 | $106.89 | $3,207 |
By year: 2022 $154K for 1,996 services; 2023 $135K for 1,624 services; 2024 $127K for 1,785 services.
Medicare prescription drug claims, 2024
In 2024, the drug Saleh Khaddash prescribed most often to Medicare patients was Levothyroxine Sodium, with 943 prescriptions and refills. In total Saleh Khaddash wrote 12,736 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 943 | 2,292 | 251 | $8,365 |
| Jardiance Empagliflozin | 756 | 1,468 | 206 | $848K |
| Metformin Hcl Generic | 752 | 1,927 | 263 | $6,880 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 715 | 1,347 | 209 | $87K |
| Ozempic Semaglutide | 592 | 799 | 108 | $746K |
| Januvia Sitagliptin Phosphate | 537 | 971 | 135 | $521K |
| Janumet Sitagliptin Phos/Metformin Hcl | 421 | 752 | 106 | $397K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 394 | 570 | 103 | $24K |
| Humalog Kwikpen U-100 Insulin Lispro | 386 | 596 | 107 | $83K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 333 | 445 | 88 | $66K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 328 | 603 | 100 | $122K |
| Novolog Flexpen Insulin Aspart | 286 | 421 | 84 | $49K |
| Gabapentin Generic | 247 | 519 | 84 | $2,679 |
| Glimepiride Generic | 201 | 542 | 79 | $2,191 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 194 | 293 | 58 | $11K |
Brand drugs: 6,036 claims; generic drugs: 5,104 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saleh Khaddash $363 ($363 in general payments such as food, travel and fees) from 6 companies. The largest payer was Madrigal Pharmaceuticals with $211.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.